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SUMMARY
Aboriginal Australians in remote communities have high rates of rheumatic heart disease
(RHD); yet pharyngitis is reportedly rare whilst pyoderma is common. Some strains of group
A streptococci (GAS) have preference for the throat and others for the skin depending on
M protein type. A study in three remote communities provided 350 GAS isolates for emm
sequence typing, 244 were also emm pattern typed. There was 100% correlation between emm
sequence and pattern type. Patterns D and E (non-throat tropic) made up 71% of throat and
87% of skin isolates although patterns A–C (throat tropic) were more common in the throat
than the skin (RR 2.3, 95% CI 1.4–3.8) whilst the opposite was found for pattern D (RR 2.2,
95% CI 1.7–3.0). Pattern E favoured the throat (RR 1.4, 95% CI 1.1–1.8). Where environmental
factors predispose to skin infection, emm pattern types D and E prevail, whatever the recovery
site.
INTRODUCTION
The burden of disease due to group A streptococcus
(GAS; Streptococcus pyogenes) varies widely from
place to place and population to population. The
relative incidence of GAS pharyngitis appears to be
higher in temperate climate regions whilst pyoderma
is less common [1–3]. In some tropical settings and
minority indigenous populations, GAS skin infection
predominates and symptomatic pharyngitis is rela-
tively rare [4–6]. Nevertheless, these populations may
still have high rates of acute rheumatic fever (ARF)
and rheumatic heart disease (RHD) [7]. Aboriginal
Australians in remote tropical communities have
some of the highest reported rates of ARF/RHD in
the world [8] and it has been hypothesized that
skin infection plays a pathogenic role in ARF in this
population [9].
The variable potential of diﬀerent stains of GAS
to cause post-streptococcal sequelae was observed
more than 60 years ago [10, 11]. In the 1950s,
Rammelkamp and others observed that GAS with
speciﬁc M serotypes appeared to cause acute post-
streptococcal glomerulonephritis (APSGN) and
these were not serotypes associated with ARF [12].
ARF was also seen to follow GAS throat infection
alone whilst APSGN occurred after either throat or
skin infection [13]. This gave rise to the concept of
separate skin and throat GAS types.
In the early 1970s, Widdowson and others demon-
strated the presence of an M-associated protein that
separated GAS into two antigenic groups (I and II)
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matching the known skin and throat types [14]. This
was subsequently shown to be due to a cell surface
lipoproteinase on skin GAS types that binds
ﬁbronectin and causes opacity in horse serum [serum
opacity factor (SOF) or streptococcal ﬁbronectin
binding protein II – SfbII] [15, 16]. Known rheuma-
togenic M types were predominantly SOF-negative.
In 1989, Bessen and co-workers diﬀerentiated two
distinct classes of M protein, based on the C repeat
region. Class I correlated with SOF-negative strains
and contained serotypes associated with outbreaks
of ARF, whereas Class II strains were associated
with skin tropism [17]. A molecular typing method
for GAS was developed in the 1990s based on
the nucleotides that determine the variable amino
terminus of the M protein on the emm gene. M
serotypes and emm types were shown to be con-
cordant [18, 19]. Subsequently, a polymerase chain
reaction (PCR)-based mapping technique further dif-
ferentiated ﬁve patterns of emm and related genes;
patterns A–C were associated with the throat, pattern
D with the skin and pattern E was found in isolates
from both throat and skin [20]. With few exceptions,
GAS isolates of a given emm sequence type (emmST)
were found to have a predictable emm pattern type
[21]. An additional genetic marker for skin preference
is plasminogen-binding group A streptococcal M
protein (PAM) [22] that is found in many GAS iso-
lates with pattern type D; it has also been associated
with invasive infection [23].
The relationship between emmST, emm pattern
type and site of GAS infection for the most part ap-
pears to hold in studies published from temperate
climates and relatively low incidence settings for
ARF [20, 24]. Yet, this is not the case for all tropical
and high-incidence settings. For example, a study of
GAS isolates from a remote Australian Aboriginal
island community found that pattern types D and
E were predominant, whatever the site of recovery
[25]. The study was limited by the paucity of throat
isolates (16/141) because GAS throat carriage was so
uncommon.
This study characterizes GAS isolates recovered
from throat and skin swabs as part of a prospective
surveillance project conducted in remote mainland
Aboriginal communities with exceptionally high rates
of ARF/RHD [26]. The aim was to conﬁrm the re-
lationship between emmST, emm pattern type, PAM
and SOF in these remote settings and to assess
whether emm pattern type correlates with the site
of GAS recovery. Finding a predominance of emm
pattern types D and E would also lend support to the
skin infection hypothesis in ARF.
MATERIALS AND METHODS
Source of GAS isolates
GAS isolates came from a longitudinal surveillance
study of streptococcal skin infection, pharyngitis and
throat carriage in three remote mainland Aboriginal
communities in the tropical Top End of the Northern
Territory, Australia. The communities (1, 2 and 3)
were separated by at least 400 km. The aim of the
study was to investigate the association of GAS
isolates with ARF in these settings [4]. The study
protocol was approved by the local ethics committee
and informed consent was obtained. Researchers
then endeavoured to visit enrolled households on a
monthly basis, for 2 years in the case of community
1 and for 1 year each in communities 2 and 3. Each
individual was asked about sore throat (in the local
language) and each throat was inspected for ery-
thema, pus and tonsillar enlargement. Throat swabs
were then taken from every person present according
to a throat swab protocol, regardless of throat symp-
toms. Children and parents were asked about the
presence of skin sores before limbs, exposed areas
and the trunk were carefully inspected. Pyoderma
was deﬁned as one or more pustular, crusted, or ves-
icular lesions or dry and inﬂamed skin ulcers >1 cm
in diameter. Non-infected insect bites and non-
inﬂamed partly healed pyoderma lesions were
excluded [4]. Swabs were taken from any skin sores.
Additional clinical and demographic information
was also collected.
Because we were unable to obtain blood samples
for serological testing, individuals were considered to
be carrying GAS in the throat if GAS was recovered
from the throat swab and they were asymptomatic at
the time.
Recovery and identiﬁcation of GAS isolates
Culture methods have been described in more detail
elsewhere [26]. Plates were incubated at 37 xC in 5%
CO2 and examined after 24 h and 48 h. Large colony-
forming beta-haemolytic streptococci (BHS) were
subcultured for identiﬁcation using a Streptococcal
Grouping kit (Oxoid Diagnostic Reagents, England,
UK). Isolates were then stored in tryptone soya broth
(Oxoid) with 15% glycerol atx70 xC.
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emm sequence type determination
The procedure for emm sequence typing followed that
recommended on the Centers for Disease Control
and Prevention (CDC) website [27] with minor modi-
ﬁcations. We used InstaGeneTM matrix (Bio-Rad,
Hercules, CA, USA) for DNA sample preparation; 20
colonies were harvested directly from culture plates
and re-suspended in 200 ml. All other steps were ac-
cording to manufacturer’s instructions. PCR was con-
ducted in 50 ml reaction volumes with 5 ml of the
InstaGeneTM preparation, 10 nmol dNTPs, 25 pmol
each of primers 1 and 2, 2.5 U Taq (Qiagen, Hilden,
NRW,Germany), 5 ml 10rTaqbuﬀer, sdH2Oto50 ml.
PCR clean-up was done using QIAquick 96 PCR
puriﬁcation kit (Qiagen), eluting in 60 ml sdH2O.
For the sequencing reaction undiluted BigDye ter-
minator version 3.1 (Applied Biosystems, Foster City,
CA, USA) premix in half volume (10 ml) with 2 ml
puriﬁed PCR product, 12.5 pmol emmseq2, 4 ml pre-
mix and 3.5 ml sdH2O was used and the reaction pro-
gram was as per protocol. Clean up was achieved by
adding 10 ml sdH2O and using DyeEx96 (Qiagen).
The product was desiccated and sent to a commercial
sequencing facility for separation. For sequence analy-
sis, electropherograms were viewed with DNAstar
Seqman software (Madison, WI, USA) and sequences
were blasted against the CDC Streptococcus pyogenes
emm sequence database [27]. Novel emm sequences
were submitted to the administrator for assignment.
emm pattern type determination
The emm pattern type was determined according to
the protocol described by Bessen et al. [25], with a
restricted set of primers as shown in Table 1.
Presence of PAM and SOF
PAM-positive emmST were diﬀerentiated by identi-
fying sequences with homology to the plasminogen-
binding A repeats of PAM within the deduced
amino-acid sequence of the translated emm sequence
data [22, 23]. Information regarding the presence of
the SOF phenotype for each emm sequence type
was obtained from the CDC website and published
sources [27, 28].
Data analysis
Data were analysed using STATA 8 (Stata Corporation,
College Station, TX, USA). Relative risks (RR) for
emm pattern types were calculated by comparing
the proportions for each site of GAS recovery and
conﬁdence intervals (CI) were calculated by standard
methods.
RESULTS
Surveillance and recovery of GAS isolates
Forty-nine households and 1173 people were enrolled.
There were 531 household visits and 4842 consul-
tations. Some of the epidemiological data have been
documented in a previous report ; symptomatic phar-
yngitis was extremely rare in study children and
pyoderma was common [4]. Three hundred and ﬁfty
GAS isolates were available for molecular typing,
222 from the throat and 128 from pyoderma lesions.
All isolates were emm sequence typed. The ﬁrst 244
GAS isolates, 150 throat and 94 skin isolates, were
also emm pattern typed (Fig. 1).
Long-term throat carriage of a speciﬁc GAS
emmST was uncommon and there were only six
people in the study who had the same emmST re-
covered from the throat on more than one occasion
(providing an extra nine isolates). If GAS of a speciﬁc
emmST was recovered from multiple skin sites from
a person on the same day, they were not counted
as multiple isolates. However, one child had emm100
recovered from skin sores for two consecutive months
(providing one extra isolate). Otherwise we did
not recover GAS from skin sores in a serial manner
from anyone else. As a result 10 GAS isolates were
removed from the analysis (Fig. 1). There were eight
instances where GAS was recovered from the skin
and the throat from one individual at the same visit ;
on four occasions they had a diﬀerent emmST in
the throat from that on the skin and four had the
same emmST at both sites. These were left in the
analysis. On 61 occasions more than one person in a
household was colonized with a speciﬁc emmST at the
same time or at a subsequent visit.
Table 1. Primer set used for emm pattern typing [25]
Primer set
Approximate size
of product (kb)
emm pattern
type(s)
UP-2 and SF1-R 1.0–2.5 A–C
SF4-A and G3-R 2.8 D or E
1.0 E
SF4-A and SF1-R 1.2–1.8 D
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Correlation of emm sequence type, emm pattern type
and site of recovery
Consistent with published data [21, 25], we found
100% concordance between emm sequence type
and emm pattern type in the ﬁrst 244 GAS isolates
from this study. We were therefore conﬁdent about
predicting the emm pattern type for the remaining
106 GAS isolates where we knew the emm sequence
type (Fig. 1). Summary data for emm sequence type,
emm pattern type and site of recovery are shown in
Table 2. The combined emm pattern data for skin
and throat isolates are shown in Figure 2. Of 213
isolates recovered from the throat, 61 were pattern
types A–C (29%) whilst 16/127 skin isolates were
types A–C (13%) (RR for throat 2.3, 95% CI
1.4–3.8). Pattern type D accounted for 67/127 (53%)
skin isolates and 51/213 throat isolates (24%) (RR
for skin 2.21, 95% CI 1.7–3.0). Pattern type E
was also more common in throat isolates (101/213,
47%), than skin isolates (44/127, 35%) (RR for
throat 1.4, 95% CI 1.1–1.8). GAS was recovered
from the throat of only two people in the study
with symptomatic pharyngitis (both adults) ; the emm
sequences types were 11 and 87 (both emm pattern
type E).
Outbreak of emm55
The data were skewed by an outbreak during
February 2005 when the prevalence of pyoderma in
children of community 3 jumped to 18% compared to
the median point prevalence of 6.1%. It coincided
with the sudden appearance of GAS emm55 (pattern
types A–C) in both skin sores (n=5) and throat
(n=18). The strain had not previously been seen in
the study. There was no discernible increase in the
incidence of sore throat or proven GAS pharyngitis,
but there was a subsequent community outbreak of
APSGN [29]. The same emm sequence type (emm55)
then appeared in community 1 during April 2005
Table 2. emm sequence types and emm pattern types
from three remote communities
emm
type
No.
throat %
No.
skin %
emm
pattern
type
1 16 100 — — A–C
12 4 100 — — A–C
12.1 1 100 — — A–C
18.12 1 100 — — A–C
19.4 1 50 1 50 A–C
55 33 70 14 30 A–C
stG653.1 5 83 1 17 A–C
33 3 25 9 75 D
42 2 67 1 33 D
53 — — 2 100 D
56 — — 1 100 D
71 11 55 9 45 D
81.2 2 67 1 33 D
91 4 29 10 71 D
91.1 2 67 1 33 D
97.1 2 50 2 50 D
98 2 50 2 50 D
99.5 — — 6 100 D
100 5 38 8 62 D
100.5 — — 1 100 D
101 2 100 — — D
105 4 100 — — D
116.1 — — 2 100 D
123 4 57 3 43 D
stNS1033 8 47 9 53 D
11 16 73 6 27 E
15.1 3 75 1 25 E
13L — — 5 100 E
22 13 100 — — E
25.1 3 100 — — E
44/61 6 55 5 45 E
58 1 100 — — E
58.8 8 100 — — E
75.1 8 89 1 11 E
76.6 3 43 4 57 E
77 1 100 — — E
78 10 100 — — E
87 2 50 2 50 E
103 12 63 7 37 E
110 2 67 1 33 E
114.2 2 40 3 60 E
st2904.1 9 60 6 40 E
stNS554 2 40 3 60 E
531 household visits
350 GAS isolates 
emm pattern on 350
GAS isolates
106 emm pattern
types derived from
emm sequence type
340 GAS isolates for analysis 
10 isolates excluded
244 GAS isolates emm
pattern typed
350 GAS isolates emm
sequence typed 
Fig. 1. Flow diagram of GAS isolates : determination of
emm pattern type.
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(skin=2 and throat=15) ; it was not accompanied by
a detectable increase in pyoderma or pharyngitis,
but it did appear to precipitate another outbreak of
APSGN (Northern Territory Centre for Disease
Control, Darwin, unpublished data). Up to the time
of the appearance of emm55, pattern types A–C
had accounted for only 12/179 (6.7%, 95% CI 4–11)
of GAS isolates. In the ﬁrst 6 months of 2005, types
A–C accounted for 65/162 (40%, 95% CI 33–48) of
GAS isolates, 72% (47/65) of those were emm55.
Overall, this sequence type accounted for 47/61 (77%)
of pattern A–C throat isolates and 14/16 (88%) of
A–C skin isolates.
Gradation of tissue tropism
Thirteen of the most common emm sequence types
(with >10 isolates) and site of recovery are shown in
Figure 3, together with PAM and SOF patterns. A
transition from pattern types A–C, through pattern
type E, and then to pattern type D can be seen as the
GAS isolates move from throat tropic to more skin
tropic. One exception is the outbreak strain, emm55.
Three of the ﬁve most common pattern D isolates
were PAM positive and SOF was positive in all six
of the common pattern E types. Pattern A–C types
(emm1 and emm55) were negative for both PAM
and SOF.
DISCUSSION
The ﬁndings of this study conﬁrm that emm pattern
type can be predicted by emm sequence type in
GAS isolates from these remote communities. This
matches the ﬁndings of McGregor et al. who studied
495 GAS isolates collected from many parts of the
world [21] including several tropical countries. The
emm gene codes for M protein, a key anti-phagocytic
virulence factor that forms the basis of M serological
typing and is responsible for evoking serotype-speciﬁc
host immunity. For the most part, speciﬁc emm
types are clonally related, when compared by multi-
locus sequence typing (MLST) using bacterial house-
keeping genes, although there are some exceptions
where one MLST sequence type is associated with
more than one emm sequence type [21]. This mainly
occurs in skin types (emm pattern D) and suggests
recombinatorial replacement of emm type. Such
recombination may be most likely to occur at
skin sites, such as in pyoderma, where multiple
GAS strains can be present together and accompanied
by selective pressure from the host immune response.
The distinction between types associated with
throat and skin appears to be most marked in
temperate regions of the northern hemisphere. M
serotypes or emm sequence types corresponding to
pattern types A–C or E predominate in throat iso-
lates from the United Kingdom, continental Europe
and the United States [2, 24, 30, 31]. By contrast,
pyoderma was found to be the dominant manifes-
tation of GAS infection in a remote Aboriginal island
community and was mainly attributable to pattern
types D (43%) and type E (40%); one reason may be
that skin isolates outnumbered throat isolates by 10:1
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Fig. 3. The most common GAS emm sequence types (>10
isolates) showing the percentages recovered from the throat
and from the skin together with emm pattern type. PAM,
Presence of the plasminogen-binding group A streptococcal
M protein genotype ; SOF, serum opacity factor.
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[25]. A–C was the most abundant pattern type in
throat isolates, but the numbers were small with only
three emmST identiﬁed. This study covered a much
larger population and produced a high proportion
of throat isolates, providing the GAS emm pattern
type distribution in widely separated mainland
Aboriginal communities that was similar to that de-
scribed in the remote island population. It is reason-
able to suggest that this emm pattern type distribution
is likely to be the norm rather than the exception
across the region.
A previous US study of serological response had
shown that patients with ARF have an elevated re-
sponse to the speciﬁc class I epitope but little response
to class II epitope [32]. In Australian Aboriginal
populations, raised levels of antibodies to class I and
class II epitopes have not been associated with any
speciﬁc disease but probably indicate the burden
of GAS exposure [33]. In this setting, it has been
suggested that the high rates of impetigo in child-
hood engender non-type speciﬁc protective immunity
against later throat colonization and pharyngitis.
This has yet to be proven.
A similar picture to that seen here has been ob-
served in a study from Ethiopia where 78 diﬀerent
emm sequence types were found in 217 GAS isolates
[34]. Pattern type E was responsible for 38% of
isolates, pattern D for 28% and patterns A–C for
18%. Patterns A–C accounted for 3% of skin iso-
lates and 24% of throat isolates. Pattern D was
also responsible for 28% of GAS pharyngitis and 4/7
of the isolates associated with ARF. Likewise
pattern types D and E dominate in populations
of north and south in India, although the rates of
throat and skin infection are markedly diﬀerent ;
the south Indian population has high rates of
pyoderma and the north Indian has high rates of
pharyngitis [35, 36].
Despite prevalence rates of RHD >25/1000 in the
three communities of this study (Northern Territory
Rheumatic Heart Disease Prevention Program,
unpublished data), pyoderma was the outstanding
manifestation of GAS infection in children and emm
pattern types D and E of GAS predominated. This
study had a much higher proportion of throat isolates
(222/350, 63%) than did a previous study conducted
among Aboriginal people living on a remote island
(16/141, 11%) [25] and provides a broader view. The
data suggest that the background rate of pattern
types A–C in the three mainland communities was
<7% but the proportion was subsequently inﬂated
by outbreaks in the two large communities of emm55
having emm pattern type A–C. Ironically, the out-
breaks involved GAS skin infections (in community
3), not pharyngitis, and were also accompanied by
outbreaks of APSGN rather than ARF. GAS M
serotype 55 has previously been associated with simi-
lar outbreaks of APSGN in the Top End of the
Northern Territory, Trinidad and elsewhere [37–39].
Another emm pattern type A–C, M/emm 12, has
been associated with outbreaks of APSGN [40] and
raises additional questions about the speciﬁcity of
emm pattern as a predictor of disease.
It has previously been pointed out that emm pattern
type is an imperfect marker of tissue tropism and
does not preclude infection at other sites [25]. Indeed,
the factors that determine tissue preference seem to
be complex; they include SOF and PAM for the
skin [15, 22] and maltodextrin utilization conferring
the ability to survive in saliva for the throat [41].
Much remains a mystery. In this study (Fig. 3),
PAM provided some indication of tissue preference;
SOF provided none. The three most throat tropic
emmST were exclusively isolated from the throat,
whereas even the most skin tropic emmST were able
to colonize the throat. Colonization of the throat
following skin infection is not uncommon [42]. These
results suggest that throat colonization is the default
condition and that the ability to cause skin infection
is probably due to the presence of one or
more skin tropic factors that are absent in throat
strains.
Our study reaﬃrms that where ecological and epi-
demiological factors predispose to skin infection, as
occurs in overcrowded tropical environments with
poor hygiene conditions [43], emm pattern types D
and E prevail and even account for the majority of
throat GAS isolates. Pyoderma is likely to remain
the predominant GAS infection in remote tropical
Australian Aboriginal communities in the absence
of eﬀective interventions [43]. There is evidence
for extensive genetic recombination between GAS
strains and this is more likely to occur where there is
a high burden of GAS colonization and infection,
especially where more than one strain occupies the
same site [44]. Despite this recombination, our study
conﬁrms concordance between emm sequence type
and emm pattern type when compared with the
published data [5, 21, 25]. We therefore also con-
clude that emm pattern typing in these tropical
settings, which is labour intensive and diﬃcult to in-
terpret, oﬀers no useful information in addition to
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that provided by emm sequence typing when in-
vestigating the epidemiology of GAS.
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